0.373

0.87% 0.0032

After Hours: .37 -0.003 -0.80%

Scienture Holdings Inc (SCNX)

Overview News Price History Discussions Forecast

Scienture Holdings Inc stock is traded at $0.373, with a volume of 140.24K. It is up +0.87% in the last 24 hours and down -0.80% over the past month. Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.

Previous Close:

$0.3698

Open:

$0.3783

24h Volume:

140.24K

Relative Volume:

0.07

Market Cap:

$15.32M

Revenue:

$656.60K

Net Income/Loss:

$-16.79M

P/E Ratio:

-0.3472

EPS:

-1.0743

Net Cash Flow:

$-11.12M

1W Performance:

-5.33%

1M Performance:

-0.80%

6M Performance:

-6.75%

1Y Performance:

-59.86%

1-Day Range:

$0.3605

$0.3783

1-Week Range:

$0.3532

$0.394

52-Week Range:

$0.2382

$2.60

Scienture Holdings Inc Stock (SCNX) Company Profile

Name

Scienture Holdings Inc

Sector

Healthcare (1074)

Industry

Pharmaceutical Retailers (8)

Phone

(800) 261 0281

Address

20 AUSTIN BLVD., COMMACK

Employee

Twitter

Next Earnings Date

2026-08-11

Latest SEC Filings

SCNX's Discussions on Twitter

Compare SCNX vs HITI, PETS, POM, RDGT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SCNX Scienture Holdings Inc	0.373	19.37M	656.60K	-16.79M	-11.12M	-1.0743
HITI High Tide Inc	2.565	215.28M	486.49M	-33.29M	10.86M	-0.3627
PETS Petmed Express Inc	1.81	38.15M	179.02M	-57.29M	-33.01M	-2.7487
POM Pomdoctor Ltd Adr	0.83	7.61M	0	0	0	0.00
RDGT Ridgetech Inc	0.9081	2.92M	111.62M	762.70K	16.36M	-85.73

Scienture Holdings Inc Stock (SCNX) Latest News

Sep 03, 2026

Enterprise value to revenue forward of Scienture Holdings, Inc. – NASDAQ:SCNX - TradingView

Sep 03, 2026

Aug 31, 2026

Scienture (SCNX) CFO shows no personal stake in company stock - Stock Titan

Aug 31, 2026

Scienture Holdings CFO Eric Sherb files initial beneficial ownership statement - Bitget

Aug 31, 2026

Aug 21, 2026

Scienture (SCNX) Levels: Finishes 4.68% Down at $0.45 on the Day; Trading Range: Price Remains Between $0.43 Support and $0.47 Resistance in the Available RecordWyckoff Upthrust - vinanet.vn

Aug 21, 2026

Aug 20, 2026

Scienture (SCNX) Quarterly Results: Profit Per Share Surpasses Its Benchmark on the Day; Post-Report: Shares Fall 0.49% in the Latest SessionEarnings Growth Forecast - vinanet.vn

Aug 20, 2026

Scienture Q2 Revenue Surges 510% Sequentially on Commercial Product Growth - Minichart

Aug 20, 2026

Scienture Q2 Revenue Reaches $343,639 as Net Loss Narrows 58% - Quiver Quantitative

Aug 20, 2026

Scienture stock jumps 21% on REZENOPY commercial launch - scanx.trade

Aug 20, 2026

Aug 19, 2026

Scienture (SCNX) Q1 2026 Results: Profit Per Share Clears Its Benchmark in the Latest Session; Closing Reaction: Shares Rise 3.76% in Latest TradingOperating Income Trends - vinanet.vn

Aug 19, 2026

Aug 18, 2026

$Scienture Holdings (SCNX.US)$ LMAO. They give us a buy rating, but wont let us buy. - Moomoo

Aug 18, 2026

Aug 17, 2026

SCNX Q1 2026 Earnings: Loss Narrower Than Expected, Shares Rise 2.18%Earnings Analysis - vinanet.vn

Aug 17, 2026

SCNX Q1 2026 Earnings: Narrower Loss Beats Estimates, but Shares SlipEarnings Analysis - vinanet.vn

Aug 17, 2026

Aug 14, 2026

Scienture Holdings 2Q Loss/Shr 7c >SCNX - moomoo.com

Aug 14, 2026

Scienture Holdings Reports Q2 2026 Results, Launches REZENOPY™ and Narrows Losses - Quiver Quantitative

Aug 14, 2026

SCNX Q2'26 Earnings: EPS estimate is (0.09) USD - TradingView

Aug 14, 2026

SCIENTURE Reports Q2 2026 Results with Approximately 510% Sequential Revenue Growth from Q1 2026 and Significant Improvement in Operating Performance - The Manila Times

Aug 14, 2026

Aug 13, 2026

Scienture Holdings: Q2 Earnings Snapshot - marketscreener.com

Aug 13, 2026

Scienture Holdings (SCNX) grows ARBLI revenue but remains loss-making in Q2 2026 - Stock Titan

Aug 13, 2026

Scienture Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 13, 2026

Aug 12, 2026

SCIENTURE Launches REZENOPY as Second FDA-Approved Commercial Product - Yahoo Finance

Aug 12, 2026

Scienture launches naloxone nasal spray for opioid overdose By Investing.com - Investing.com Nigeria

Aug 12, 2026

Scienture launches naloxone nasal spray for opioid overdose - Investing.com

Aug 12, 2026

SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray - marketscreener.com

Aug 12, 2026

Scienture Holdings Announces Commercial Launch and Fulfillment of Initial Purchase Orders of Rezenopy Nasal Spray 10 Mg - marketscreener.com

Aug 12, 2026

EXCLUSIVE: Scienture Launches Highest-Dose Naloxone Nasal Spray Rezenopy in US - Yahoo Finance

Aug 12, 2026

Aug 07, 2026

Scienture Holdings Inc expected to post a loss of 23 cents a shareEarnings Preview - TradingView

Aug 07, 2026